Literature DB >> 9153494

Meningiomas: the decision not to operate.

J B Braunstein1, N A Vick.   

Abstract

In a consecutive series of 100 patients diagnosed with meningiomas, we advised 12 patients not to have surgery, and followed them from 3.3 to 12.8 years (mean, 8.8 years). The two determinants of this decision were either absence of related neurologic symptoms or signs and concern about high operative risk of neurologic impairment. Serial imaging studies showed meningioma growth in only one of the 12 unoperated patients and only one had convincing progression of neurologic impairment.

Entities:  

Mesh:

Year:  1997        PMID: 9153494     DOI: 10.1212/wnl.48.5.1459

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  Salvage chemotherapy with CPT-11 for recurrent meningioma.

Authors:  Marc C Chamberlain; Denice D Tsao-Wei; Susan Groshen
Journal:  J Neurooncol       Date:  2006-04-21       Impact factor: 4.130

2.  Definitive embolization of meningiomas. A review.

Authors:  B T Bateman; E Lin; J Pile-Spellman
Journal:  Interv Neuroradiol       Date:  2005-10-25       Impact factor: 1.610

Review 3.  Primary brain tumors in the elderly.

Authors:  Lakshmi Nayak; Fabio M Iwamoto
Journal:  Curr Neurol Neurosci Rep       Date:  2010-07       Impact factor: 5.081

4.  Anatomic location is a risk factor for atypical and malignant meningiomas.

Authors:  Ari J Kane; Michael E Sughrue; Martin J Rutkowski; Gopal Shangari; Shanna Fang; Michael W McDermott; Mitchel S Berger; Andrew T Parsa
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

5.  Meningiomas.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2001-01       Impact factor: 3.598

6.  Natural history of elderly patients with asymptomatic meningiomas.

Authors:  M Niiro; K Yatsushiro; K Nakamura; Y Kawahara; J Kuratsu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-01       Impact factor: 10.154

7.  "You can observe a lot by just watching" (Yogi Berra).

Authors:  Marc C Chamberlain
Journal:  Neuro Oncol       Date:  2022-01-05       Impact factor: 13.029

8.  Growth rate of non-operated meningiomas.

Authors:  L A Zeidman; W J Ankenbrandt; Hongyan Du; N Paleologos; N A Vick
Journal:  J Neurol       Date:  2008-03-20       Impact factor: 4.849

9.  Intracerebral Meningiomas.

Authors:  Marc C. Chamberlain
Journal:  Curr Treat Options Neurol       Date:  2004-07       Impact factor: 3.598

10.  Natural History of Meningiomas: Review with Meta-analyses.

Authors:  Satoshi Nakasu; Yoko Nakasu
Journal:  Neurol Med Chir (Tokyo)       Date:  2020-01-31       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.